An anti-estrogenic lignan glycoside, tracheloside, from seeds of Carthamus tinctorius

Biosci Biotechnol Biochem. 2006 Nov;70(11):2783-5. doi: 10.1271/bbb.60290. Epub 2006 Nov 7.

Abstract

The lignan glycoside, tracheloside, was isolated from seeds of Carthamus tinctorius (Compositae) as an anti-estrogenic principle against cultured Ishikawa cells by employing a bioassay-linked HPLC-ELSD method. Tracheloside significantly decreased the activity of alkaline phosphatase (AP), an estrogen-inducible marker enzyme, with an IC(50) value of 0.31 microg/ml, a level of inhibition comparable to that of tamoxifen (IC(50) = 0.43 microg/ml).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Butyrolactone / analogs & derivatives*
  • 4-Butyrolactone / chemistry
  • 4-Butyrolactone / pharmacology
  • Carthamus tinctorius / chemistry*
  • Cell Line
  • Enzyme Activation / drug effects
  • Estrogens / metabolism*
  • Glucosides / chemistry
  • Glucosides / pharmacology*
  • Glycosides / chemistry*
  • Glycosides / metabolism
  • Glycosides / pharmacology*
  • Lignans / chemistry*
  • Lignans / metabolism
  • Molecular Structure
  • Plant Extracts / chemistry
  • Seeds / chemistry
  • Solubility

Substances

  • Estrogens
  • Glucosides
  • Glycosides
  • Lignans
  • Plant Extracts
  • tracheloside
  • 4-Butyrolactone